← FDA DRUG APPROVALS

FDA ANDA · ANDA089129

TRIAMCINOLONE ACETONIDE

Sponsor: COSETTE PHARMS NC

APPLICATION
ANDA089129
TYPE
ANDA
ORIGINAL APPROVAL
1986-08-14
LATEST ACTION
2000-03-23
ROUTE
TOPICAL
DOSAGE FORM
LOTION
MARKETING STATUS
Prescription

Products

TRIAMCINOLONE ACETONIDEPrescription
TRIAMCINOLONE ACETONIDE 0.1% · LOTION · TOPICAL

Approval history

2000-03-23Manufacturing (CMC) · Supplement 14AP
2000-03-23Manufacturing (CMC) · Supplement 15AP
1993-04-08Labeling · Supplement 13AP
1993-03-29Labeling · Supplement 11AP
1991-12-03Labeling · Supplement 9AP
1991-03-05Labeling · Supplement 8AP
1990-01-03Manufacturing (CMC) · Supplement 7AP
1989-02-09Labeling · Supplement 6AP
1988-04-21Labeling · Supplement 4AP
1986-08-14OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →